Document:

EX-10.22

 Exhibit 10.22 
  

					
		 		 	Type: Management Rollover Stock Appreciation Right
		 		 	Name:
		 		 	Number of Shares Subject to Rollover SARs:
		 		 	Price per Share: $[        ]
		 		 	Date of Grant:

 HEALTHCARE TECHNOLOGY HOLDINGS, INC. 

2010 EQUITY INCENTIVE PLAN 

THIS AWARD AND ANY SECURITIES ISSUED UPON EXERCISE OF THIS STOCK APPRECIATION RIGHT ARE SUBJECT TO RESTRICTIONS ON VOTING AND TRANSFER AND
REQUIREMENTS OF SALE AND OTHER PROVISIONS AS SET FORTH IN THE MANAGEMENT STOCKHOLDERS AGREEMENT (AS DEFINED IN THE HEALTHCARE TECHNOLOGY HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN). 

HEALTHCARE TECHNOLOGY HOLDINGS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH RESPECT TO
YOUR AWARD AND ITS TAX CONSEQUENCES. 
 MANAGEMENT ROLLOVER STOCK
APPRECIATION RIGHT AGREEMENT 
 This agreement (the
“Agreement”) evidences a rollover stock appreciation right granted by Healthcare Technology Holdings, Inc. (the “Company”) to the undersigned (the “Grantee” and together with the Company, the
“Parties”), pursuant to and subject to the terms of the Healthcare Technology Holdings, Inc. 2010 Equity Incentive Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference. Unless
defined herein, all capitalized terms shall have the meaning set forth in the Plan. 
 WHEREAS, on
[            ], the Company, Healthcare Technology Acquisition, a Delaware corporation and indirect, wholly owned subsidiary of the Company (“Merger Sub”), and IMS Health
Incorporated (“IMS”), a Delaware corporation, entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which Merger Sub will merge with and into IMS, with IMS as the surviving corporation
(the “Merger”) on the terms and subject to the conditions set forth in the Merger Agreement; 
 WHEREAS, immediately prior
to the Merger, the Grantee held certain stock appreciation rights (the “IMS SARs”), that were granted pursuant to the IMS Health Incorporated 2000 Stock Incentive Plan or the 1998 IMS Health Incorporated Employees’ Stock
Incentive Plan (including predecessor plans, collectively, the “IMS Plans”) with respect to shares of IMS common stock, all of which became fully vested in connection with the Merger; 

 WHEREAS, the Company has agreed to substitute stock appreciation rights with respect to shares of
Stock on the terms hereinafter set forth (the “Rollover SARs”) in exchange for the IMS SARs; 
 NOW, THEREFORE, in
consideration of the mutual covenants and agreements contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: 

1. Treatment of IMS SARs. Each IMS SAR previously entitling the Grantee to acquire shares of IMS stock on the terms set forth in such
IMS SAR and the applicable IMS Plan is hereby exchanged for a Rollover SAR to acquire, in whole or in part, on the terms provided herein and in the Plan, the number of shares of Stock set forth on Schedule I (the “Shares”) with an
exercise price per share of Stock as set forth on Schedule I across from such Rollover SAR, in each case subject to adjustment pursuant to Section 7 of the Plan in respect of transactions following the date hereof. The exchange of Rollover SARs
for IMS SARs is intended to qualify as a stock right substitution under Treas. Regs. §1.409A-1(b)(5)(v)(D) and shall be construed accordingly. Without limiting the foregoing, each Rollover SAR shall (i) be fully vested at all times;
(ii) expire not later than the latest date on which the corresponding IMS SAR would have expired (the “Final Exercise Date”); and (iii) be governed in all respects by the terms of the corresponding IMS SAR, except for
(A) the number and type of shares of Stock subject to the Rollover SAR, (B) the exercise price of the Rollover SAR, (C) the provisions of Section 7 of the Plan, (D) the provisions of the Plan applicable to governance,
amendment, termination, administration, interpretation and similar matters, (E) the provisions set forth in Section 7 of this Agreement and (F) all other provisions of the Plan that as applied to the Rollover SAR would not be treated
as inconsistent with satisfaction of the requirements of Treas. Regs. § 1.409A-1(b)(5)(v)(D). The Rollover SAR is granted to the Grantee in connection with the Grantee’s employment by the Company in substitution of an IMS SAR. 

2. Representations and Warranties of the Company. The Company represents and warrants to the Grantee that the statements in this
Section 2 are true and correct as of the date of this Agreement. 
  

	 	(a)	Organization of the Company. The Company is a corporation duly organized and validly existing under the laws of the State of Delaware. 

 

	 	(b)	Authorization, Execution and Delivery of the Agreement. The Company has the capacity, full corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by the Company and constitutes the valid and legally binding obligation of the Company, enforceable in accordance with its terms and conditions. The
Company need not give any notice to, make any filing with, or obtain any authorization, consent, or approval of any government or governmental agency in order to consummate the transactions contemplated by this Agreement. 

  
 -2- 

	 	(c)	Valid Issuance of the Rollover SARs. The shares of Stock issuable upon exercise of the Rollover SARs that are being granted to the Grantee hereunder, when issued in accordance with the terms hereof for the
consideration expressed herein, will be validly issued, fully paid and nonassessable. 

 3. Representations and Warranties
of the Grantee. The Grantee represents and warrants to the Company that the statements in this Section 3 are true and correct as of the date of this Agreement. 
  

	 	(a)	Ownership of IMS Securities. The Grantee holds and is the owner of the IMS SARs. Except for the provisions of the applicable IMS Plan and any transfer restrictions under applicable securities law, the IMS SARs
are held free and clear of all mortgages, liens, licenses, pledges, charges, claims, security interests, encumbrances, agreements, rights of first refusal, options or restrictions of any kind whatsoever (including, without limitation, restrictions
on the right to sell or otherwise dispose of such IMS SARs) or other defects in title. 

  

	 	(b)	Authorization, Execution and Delivery of the Agreement. The Grantee has the capacity, full power and authority to execute and deliver this Agreement, to perform the Grantee’s obligations hereunder, and to
consummate the transactions contemplated hereby. This Agreement has been duly executed and delivered by the Grantee and constitutes the valid and legally binding obligation of the Grantee, enforceable in accordance with its terms and conditions. The
Grantee need not give any notice to, make any filing with, or obtain any authorization, consent, or approval of any government or governmental agency in order to consummate the transactions contemplated by this Agreement. 

 

	 	(c)	Investment. The Grantee understands that the holding of Rollover SARs involves substantial risk. The Grantee understands that, following the effective time of the Merger, IMS, as the surviving corporation of the
Merger, intends to file a Form 15 to deregister the IMS common stock under the Securities Exchange Act of 1934, as amended, and suspend its duty to file periodic and current reports thereunder. There is not expected to be any public or other market
for the Shares, and there can be no assurance as to when, or whether, any such market will develop. The Grantee is electing to receive the Rollover SARs for his or her own account, for investment purposes only and not with a view to the distribution
or public offering thereof in violation of the United States Securities Act of 1933, as amended (the “Securities Act”), or any applicable United States federal or state securities laws or regulations. 

  
 -3- 

	 	(d)	No Registration. The Grantee has been advised that neither the Rollover SARs nor the shares of Stock issuable upon exercise thereof are being registered under the Securities Act, upon the basis that the
transaction is exempt from such registration requirements pursuant to regulations promulgated by the Securities and Exchange Commission, and that reliance by the Company on such exemptions are predicated in part on the Grantee’s representations
set forth herein, and, as a result, none of the Rollover SARs, or any shares issued upon exercise or distribution thereof, may be transferred, sold, offered for sale, pledged, hypothecated or otherwise disposed of without registration under the
Securities Act and any other provisions of applicable state securities laws or pursuant to an applicable exemption therefrom. The Grantee is aware that the Company is not under any obligation to effect any such registration with respect to the
Rollover SARs or the shares of Stock issuable upon exercise thereof or to file for or comply with any exemption from registration. The Grantee further acknowledges that his or her rights and interests under and with respect to the Rollover SARs and
Shares issued upon any exercise or distribution thereof will be subject to the terms and conditions of the Plan and the Management Stockholders Agreement and the Grantee will have no further rights under the IMS SARs exchanged for such Rollover
SARs. The Grantee has such knowledge and experience in financial and business matters that the Grantee is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment and is able to bear the
economic risk of such investment for an indefinite period of time. The Grantee is an “accredited investor” as that term is defined in Regulation D under the Securities Act. The address of the Grantee is as set forth under the
Grantee’s name on the signature page hereof. 

  

	 	(e)	No Other Representations or Warranties; Acknowledgments. No representations or warranties, oral or otherwise, have been made to the Grantee (or any party acting on the Grantee’s behalf) in connection with
the offer and issuance of the Rollover SARs other than the representations and warranties specifically set forth in this Agreement. The Grantee has had an opportunity to consult an independent tax and legal advisor and the Grantee’s decision to
enter into this Agreement has been based solely upon the Grantee’s evaluation. The Grantee is aware that the Management Stockholders Agreement provides significant restrictions on the Grantee’s ability to transfer or dispose of the
Rollover SARs and the shares of Stock issuable upon exercise thereof. 

  

	 	(f)	 Disclosure. The Grantee is employed by IMS or one of its subsidiaries. In connection with the Grantee’s exchange of IMS SARs for Rollover
SARs, the Grantee has received a copy of the proxy statement dated December 29, 2009 related to the Merger and a confidential memorandum dated February 17, 2010 relating to the opportunity to invest in the Rollover SARs and describing the
equity securities of the Company, including the Rollover SARs, and has been given access to all other information 

  
 -4- 

	 	
regarding the financial condition and the proposed business and operations of the Company, IMS and its subsidiaries that the Grantee has requested in order to evaluate his or her investment in
the Company. The Company has made available to the Grantee the opportunity to ask questions of, and to receive answers from, persons acting on behalf of the Company and IMS concerning the terms and conditions of the offering of the Rollover SARs,
and to obtain any additional information desired by the Grantee with respect to the Company, IMS and its subsidiaries. 

 4.
Share Restrictions, Etc. Not later than upon the execution of this Agreement and effective as of the date hereof, the Grantee has executed and become a party to the Management Stockholders Agreement. Except as expressly provided herein, the
Grantee’s rights hereunder and with respect to Shares received upon exercise are subject to the restrictions and other provisions contained in the Management Stockholders Agreement. 

5. Legends, Etc. Shares issued upon exercise shall bear such legends as may be required or provided for under the terms of the
Management Stockholders Agreement. 
 6. Transfer of Rollover SARs. Any transfer of Rollover SARs by a Grantee shall be governed by
and subject to the terms and conditions of the Plan. 
 7. Exercise. The Rollover SAR shall be exercised by the Grantee under the
terms set forth in the Plan, as modified by this Section 7. Upon a cessation of Employment, the Grantee shall be entitled to exercise the Rollover SAR until the Final Exercise Date. Notwithstanding the foregoing, if the Grantee’s
Employment terminates as a result of a voluntary resignation without Good Reason (other than Retirement) on or prior to [            ] or as a result of a termination by the Company for
Cause, or if the Grantee Competes (as such term is defined in the Management Stockholders Agreement) with the Company within eighteen (18) months of any cessation of Employment, the Grantee shall be required to exercise the Rollover SAR within
ninety (90) days of such cessation of Employment or within thirty (30) days of the date on which the Company receives notice that the Grantee has Competed, as applicable. The Rollover SAR, to the extent not so exercised, shall terminate at
the expiration of such period with no consideration due to the Grantee. 
 8. Withholding. The exercise of the Rollover SARs will
give rise to “wages” subject to withholding. The Grantee expressly acknowledges and agrees that the Grantee’s rights hereunder, including the right to be issued Shares upon exercise, are subject to the Grantee promptly paying to the
Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld. In the event of an exercise of the Rollover SAR, or a portion of the Rollover SAR, in connection with or
following a cessation of Employment as result of death, Disability, termination by the Company without Cause, voluntary resignation for Good Reason or the Grantee’s Retirement, or a voluntary resignation without Good Reason after
[            ], or in the event of an exercise of the Rollover SAR, or a portion of the Rollover SAR, on or immediately prior to the Final Exercise Date while the Grantee

  
 -5- 

 
remains employed, the Grantee may elect to have shares of Stock held back by the Company having a Fair Market Value equal to the applicable minimum tax withholding requirements in accordance with
the Plan. The Grantee also authorizes the Company and its subsidiaries to withhold such amount from any amounts otherwise owed to the Grantee and the Company may so withhold. 

9. Effect on Employment. Neither the grant of the Rollover SARs, nor the issuance of Shares upon exercise of the Rollover SARs, shall
give the Grantee any right to be retained in the employ of the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to discharge or discipline such Grantee at any time, or affect any right of such Grantee to
terminate his or her Employment at any time. 
 10. Termination. The Grantee hereby acknowledges and agrees that none of the Company
or any of its subsidiaries, or any of their respective officers, directors or employees shall have any liability or obligation to the Grantee as a result of this Agreement in the event the Merger Agreement is terminated (or the Merger otherwise does
not occur), and that nothing set forth in this Agreement shall limit or otherwise affect the Company’s ability to exercise any of its rights under the Merger Agreement, including its rights under Article VIII thereof. This Section 10 shall
survive any termination of this Agreement. 
 11. Governing Law. This Agreement and all claims or disputes arising out of or based
upon this Agreement or relating to the subject matter hereof shall be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that
would cause the application of the domestic substantive laws of any other jurisdiction. 
 By acceptance of the Rollover SARs, the
undersigned agrees hereby to become a party to, and be bound by the terms of, the Management Stockholders Agreement. 
 [The remainder of
this page is intentionally left blank] 

  
 -6- 

 Executed as of the      day of
            ,         . 
  

							
	Healthcare Technology Holdings, Inc.	 		 	HEALTHCARE TECHNOLOGY HOLDINGS, INC.
				
		 		 	By:	 	  

		 		 		 	Name:
		 		 		 	Title:

					
	Grantee	 		 	  

		 		 	Name:
			
		 		 	Address:

 [Signature Page to Management Rollover Stock Appreciation Rights Agreement]EX-10.23

 Exhibit 10.23 
  

			
		 	Type: Special Time-Based Option
		 	Name: Ari Bousbib
		 	 Number of Shares Subject to
 Option:
10,000,000

		 	Price per Share: $1.50
		 	Date of Grant: September 1, 2010

 HEALTHCARE TECHNOLOGY HOLDINGS, INC. 

2010 EQUITY INCENTIVE PLAN 

THIS AWARD AND ANY SECURITIES ISSUED UPON EXERCISE OF THIS OPTION ARE SUBJECT TO RESTRICTIONS ON VOTING AND TRANSFER AND REQUIREMENTS OF
SALE AND OTHER PROVISIONS AS SET FORTH IN THE MANAGEMENT STOCKHOLDERS AGREEMENT (AS DEFINED IN THE HEALTHCARE TECHNOLOGY HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN). 

HEALTHCARE TECHNOLOGY HOLDINGS, INC. STRONGLY ENCOURAGES YOU TO SEEK THE ADVICE OF YOUR OWN LEGAL AND FINANCIAL ADVISORS WITH RESPECT TO
YOUR AWARD AND ITS TAX CONSEQUENCES. 
 SENIOR MANAGEMENT NONSTATUTORY
OPTION AGREEMENT 
 1. Grant of Option. This agreement (the
“Agreement”) evidences the grant by Healthcare Technology Holdings, Inc. (the “Company”) to the undersigned (the “Optionee”) on September 1, 2010 (the “Date of Grant”) of an
option (the “Option”) under the Healthcare Technology Holdings, Inc. 2010 Equity Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference, to purchase, in whole or in part, on the terms
provided herein and in the Plan, the number of shares of Stock set forth in Schedule A (the “Shares”) with an exercise price of $1.50 per share (150% of the Fair Market Value of the Stock on the Date of Grant), in each case subject
to adjustment pursuant to Section 7 of the Plan. The Option will vest in accordance with Section 3 below. 
 The Option evidenced
by this Agreement is intended to be a nonstatutory option (that is, an option not described in subsection (b) of Section 422) and is granted to the Optionee in connection with the Optionee’s Employment by the Company and its
qualifying subsidiaries. For purposes of the immediately preceding sentence, “qualifying subsidiary” means a subsidiary of the Company as to which the Company has a “controlling interest” as described in Treas. Regs.
§ 1.409A-1(b)(5)(iii)(E)(1). 

 2. Meaning of Certain Terms. Except as otherwise defined herein, all capitalized terms
used in this Agreement shall have the same meaning as in the Plan. The following terms shall have the following meanings: 

(a) “Beneficiary” means, in the event of the Optionee’s death, the beneficiary named in the written
designation (in form acceptable to the Administrator) most recently filed with the Administrator by the Optionee prior to death and not subsequently revoked, or, if there is no such designated beneficiary, the executive or administrator of the
Optionee’s estate. An effective beneficiary designation shall be treated as having been revoked only upon receipt by the Administrator, prior to the Optionee’s death, of an instrument of revocation in form acceptable to the Administrator.
If the Option or any portion thereof has been transferred to a Permitted Transferee who is a natural person and such Permitted Transferee dies while the Option or transferred portion thereof is outstanding, the Option or portion thereof so
transferred may thereafter be exercised, to the extent it remains exercisable and subject to such limitations as the Administrator may impose, by the person or persons to whom it passed from the Permitted Transferee by the applicable laws of descent
and distribution. 
 (b) “Employment Agreement” means the Employment Agreement between the Optionee, the
Company and IMS Health Incorporated dated as of August 16, 2010 and effective as of September 1, 2010. 
 (c)
“Option Holder” means the Optionee or, if as of the relevant time the Option has passed to a Beneficiary or Permitted Transferee, the Beneficiary or Permitted Transferee, as the case may be, who holds the Option pursuant to the
terms of this Agreement. 
 (d) “Permitted Transferee” means a transferee of the Option pursuant to a
transfer described at Section 7 below. 
 3. Vesting; Method of Exercise; Treatment of the Option Upon Cessation of Employment.

 (a) Generally. As used herein with respect to the Option or any portion thereof, the term “vest” means to
become exercisable. Unless earlier terminated, relinquished or expired, the Options shall vest in accordance with the terms of Schedule A applicable thereto. 

(b) Exercise of the Option. No portion of the Option may be exercised until such portion vests. Each election to
exercise any vested portion of the Option shall be subject to the terms and conditions of the Plan and shall be in writing, signed by the Optionee or by the Beneficiary or Permitted Transferee to whom such portion of the Option has passed (subject
to any restrictions provided under the Plan and the Management Stockholders Agreement). Each such written exercise election must be received by the Company at its principal office and be accompanied by payment in full as provided in the Plan. The
purchase price may be paid (i) by cash or check acceptable to the Administrator, (ii) by such other means, if any, as may be acceptable to the Administrator, or (iii) by any combination of the foregoing permissible forms of payment;
provided, however, that in addition to the foregoing, in the event of an exercise of the Option, or a portion of the Option, in connection with 

  
 -2- 

 
or following a cessation of Employment as result of death, Disability, termination by the Company without Cause, voluntary resignation for Good Reason, an Expiration Termination (as defined in
the Employment Agreement), the Optionee’s Retirement, or a voluntary resignation without Good Reason after September 1, 2013, or in the event of an exercise of the Option, or a portion of the Option on or immediately prior to the Final
Exercise Date while the Optionee remains employed, the purchase price may be paid, at the Optionee’s election, on a cashless basis under which shares of Stock otherwise deliverable under the Option and having a Fair Market Value equal to the
exercise price are withheld by the Company in accordance with the Plan. In the event that the Option is exercised by a person other than the Optionee, the Company will be under no obligation to deliver Shares hereunder unless and until it is
satisfied as to the authority of the Option Holder to exercise the Option. The latest date on which the Option or any portion thereof may be exercised is the 10th anniversary of the Date of Grant, (the “Final Exercise Date”), and if
not exercised by such date the Option or any remaining portion thereof will thereupon immediately terminate. 
 (c)
Treatment of the Option Upon Cessation of Employment. If the Optionee’s Employment ceases, the Option to the extent not already vested will be immediately forfeited and any vested portion of the Option will be treated as follows: 

(i) Subject to (ii), (iii), (iv), (v) and (vi) below, the Option, to the extent exercisable immediately prior to the
cessation of the Optionee’s Employment, will remain exercisable until the earlier of (i) 30 days following cessation of Employment or (ii) the Final Exercise Date, and, unless previously exercised, will thereupon immediately
terminate. 
 (ii) In the event of cessation of the Optionee’s Employment by reason of death or Disability, the Option,
to the extent exercisable immediately prior to Optionee’s death or Disability, will remain exercisable until the earlier of (i) the first anniversary of the Optionee’s death or Disability, or (ii) the Final Exercise Date, and,
unless previously exercised, will thereupon immediately terminate. 
 (iii) In the event of cessation of the Optionee’s
Employment by the Company without Cause, by the Optionee for Good Reason, or upon an Expiration Termination, the Option, to the extent exercisable immediately prior to the cessation of the Optionee’s Employment, will remain exercisable until
the earlier of (i) 90 days following cessation of Employment, or (ii) the Final Exercise Date, and, unless previously exercised, will thereupon immediately terminate. 

(iv) In the event of cessation of the Optionee’s Employment due to the Optionee’s Retirement, the Option, to the
extent exercisable immediately prior to the cessation of the Optionee’s Employment, will remain exercisable until the earlier of (i) 90 days following cessation of Employment, or (ii) the Final Exercise Date, and, unless previously
exercised, will thereupon immediately terminate. 

  
 -3- 

 (v) The Option will terminate immediately prior to a cessation of the
Optionee’s Employment if such cessation of Employment has resulted in connection with an act or failure to act constituting Cause. 

(vi) In the event the Optionee terminates Employment for any reason and, within 24 months of such termination date, breaches
any non-competition or non-solicitation covenant or materially breaches any confidentiality, non-disclosure or other similar covenant, the Option will be treated as having terminated immediately prior to such cessation of Employment. 

4. Share Restrictions, etc. Except as expressly provided herein, the Optionee’s rights hereunder and with respect to Shares
received upon exercise are subject to the restrictions and other provisions contained in the Management Stockholders Agreement. 
 5.
Legends, etc. Shares issued upon exercise shall bear such legends as may be required or provided for under the terms of the Management Stockholders Agreement. 

6. Transfer of Option. The Option may only be transferred to a legal representative in the event of the Optionee’s incapacity or
to one or more transferees permitted under Section 6(a)(3) of the Plan. 
 7. Withholding. The exercise of the Option will give
rise to “wages” subject to withholding. The Optionee expressly acknowledges and agrees that the Optionee’s rights hereunder, including the right to be issued Shares upon exercise, are subject to the Optionee promptly paying to the
Company in cash (or by such other means as may be acceptable to the Administrator in its discretion) all taxes required to be withheld. In the event of an exercise of the Option, or a portion of the Option, in connection with or following a
cessation of Employment as result of death, Disability, termination by the Company without Cause, voluntary resignation for Good Reason, an Expiration Termination, the Optionee’s Retirement, or a voluntary resignation without Good Reason after
September 1, 2013, or in the event of an exercise of the Option, or a portion of the Option, on or immediately prior to the Final Exercise Date while the Optionee remains employed, the Optionee may elect to have shares of Stock held back by the
Company having a Fair Market Value equal to the applicable minimum tax withholding requirements in accordance with the Plan. The Optionee also authorizes the Company and its subsidiaries to withhold such amount from any amounts otherwise owed to the
Optionee and the Company may so withhold. 
 8. Treatment of the Option upon Consummation of a Covered Transaction. Notwithstanding
Section 7(a)(3) of the Plan that permits the Administrator, in its discretion, to accelerate the exercisability of Awards in connection with a Covered Transaction in which there is no assumption, continuation, substitution or cash-out of an
Award, the portion of the Option that is outstanding immediately prior the consummation of a Covered Transaction, to the extent that it is not assumed, continued, substituted or cashed-out in connection with the Covered Transaction in accordance
with the terms of the Plan, shall vest in full immediately prior to the consummation of such Covered Transaction. 

  
 -4- 

 9. Effect on Employment. Neither the grant of the Option, nor the issuance of Shares upon
exercise of the Option, shall give the Optionee any right to be retained in the employ of the Company or any of its Affiliates, affect the right of the Company or any of its Affiliates to discharge or discipline such Optionee at any time, or affect
any right of such Optionee to terminate his or her Employment at any time. 
 10. Other Undertakings. 

(a) To protect the interests of the Company and its direct and indirect subsidiaries (collectively, the “IMS
Companies”), including the confidential information of the IMS Companies and the confidential information of their respective customers, data suppliers, prospective customers and other companies with which the IMS Companies have a business
relationship, and in consideration of the covenants and promises and other valuable consideration described in this Agreement, the Company and the Optionee agree as follows: 

(b) The Optionee acknowledges and agrees that he is bound by the confidentiality and other covenants contained in the
restrictive covenant and confidentiality agreements that he has executed with an IMS Company, which covenants and agreements are incorporated herein by reference and shall survive any exercise, expiration, forfeiture or other termination of this
Agreement or the Option issuable hereunder. The Optionee also acknowledges and agrees that the Company shall be an affiliate for purposes of such restrictive covenant and confidentiality agreements. 

(c) The Optionee acknowledges the opportunity to participate in the Plan and the financial benefits that may accrue from such
participation, is good, valuable and sufficient consideration for the following: 
 (i) The Optionee acknowledges and agrees
that he is and will remain bound by the non-competition and non-solicitation covenants contained in the Employment Agreement. 

(ii) The Optionee further acknowledges and agrees that the remedies available for breach of any non-competition or
non-solicitation covenants shall include, but not be limited to, the following: (v) actual damages, (w) all equitable remedies available to the Company, (x) the rights and remedies of the Company set forth in Section 5 of the
Management Stockholders Agreement, (y) the forfeiture of the Option for no consideration, and (z) in respect of the Option (or portion thereof) exercised by the Optionee prior to any such breach or subsequent thereto and prior to the
forfeiture of such award required by this Section 12(c)(ii), the Optionee shall pay to the Company an amount equal to the difference between the exercise price of the Option and the per-share proceeds of any sale of Stock acquired upon such
exercise multiplied by the number of shares of Stock so sold. 

  
 -5- 

 The Company shall also be entitled to the foregoing remedies in the event of a material breach of
any confidentiality, non-disclosure or other similar covenant contained in the restrictive covenant and confidentiality agreements that the Optionee has executed with an IMS Company. 

11. Governing Law. This Agreement and all claims arising out of or based upon this Agreement or relating to the subject matter hereof
shall be governed by and construed in accordance with the domestic substantive laws of the State of Delaware without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic substantive laws
of any other jurisdiction. 
 12. Provisions of the Plan. This Agreement is subject in its entirety to the provisions of the Plan,
which are incorporated herein by reference. A copy of the Plan as in effect on the Date of Grant has been furnished to the Optionee and the Optionee agrees to be bound by the terms of the Plan and this Agreement. In the event of any conflict between
the terms of this Agreement and the terms of the Plan, the terms of this Agreement shall control. The Company acknowledges and agrees that, for purposes of this Agreement and the Plan, the terms “Cause” and “Good Reason” shall be
determined in accordance with and pursuant to the Employment Agreement. 
 13. S-8 Registration. As soon as practicable after the
time that Shares are first registered by the Company pursuant to an effective registration on Form S-1, the Company shall register the Shares, issuable to the Optionee upon the exercise of any portion of the Option, pursuant to a Form S-8 (or
successor registration form); provided that the Optionee shall agree to bound by any applicable lock-up agreement in connection with such registration, pursuant to Section 3.6 of the Management Stockholders Agreement or otherwise. 

By acceptance of the Option, the undersigned agrees hereby to become a party to, and be bound by the terms of, the Management Stockholders
Agreement. 
 [The remainder of this page is intentionally left blank] 

  
 -6- 

 Executed as of the      day of September, 2010. 

 

							
	Healthcare Technology Holdings, Inc.	 		 	HEALTHCARE TECHNOLOGY HOLDINGS, INC.
				
		 		 	By:	 	  

			
	Optionee	 		 	  

		 		 	Name: Ari Bousbib

 [Signature Page to Senior Management Nonstatutory Option Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00225-of-00352.parquet"}]]